Epoch Biodesign

Epoch Biodesign is a biotech startup developing plastic-eating enzymes to disrupt the plastic pollution cycle by powering up biorecycling-based circularity. Their core mission is to transform plastic waste, initially focusing on common synthetic fabrics like polyester and nylon, back into reusable materials. They leverage AI to accelerate the discovery of biological catalysts and aim to make recycling a cheaper and more efficient alternative to producing new plastic.

Funding Round: Series A

Funding Amount: $18.3M

Date: 05-Mar-2025

Investors: Extantia Capital, Day One Ventures, Happiness Capital, Kibo Invest, Lowercarbon Capital, Inditex

Markets: Biotech, Cleantech, Synthetic Biology

HQ: London, United Kingdom

Founded: 2019

Website: https://www.epochbiodesign.com

LinkedIn: https://www.linkedin.com/company/epochbiodesign

Twitter: https://twitter.com/epochbio

Instagram:

Facebook: